GO
Loading...

Germany's Bayer Sells Wolff Walsrode Unit to Dow Chemical

Bayer AG said Monday it is selling its Wolff Walsrode business, which specializes in cellulose products, to the Dow Chemical Co. for an undisclosed sum.

Leverkusen-based Bayer said in March that it would divest Wolff Walsrode as part of plans to finance its acquisition of fellow German drug maker Schering AG, a deal that was worth nearly US$22.1 billion.

The sale to Midland, Michigan-based Dow is expected to close in the first half of next year, subject to regulatory approval, Bayer said.

Wolff Walsrode employs about 1,500 people and had sales of US$430 million last year.

It is to become part of Dow's Water Soluble Polymers business.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Mad Money host Jim Cramer dissects the biggest red flags for investors right now, and what the Treasury's newest tax inversion rules mean for your money.

  • Natural gas is down nearly 10 percent so far this year. Mad Money host Jim Cramer goes off the charts with the help of technician Carley Garner's take on nat gas' next direction.

  • The FDA authorized Tekmira's ebola drug for potential use through an expanded access program. CNBC's Meg Tirrell reports which other companies are working on drugs to fight ebola.